Plenty of news to bring you across medical devices and biotech this morning. Deal news incldes headlings from neuromodulation, protein degraders, sleep technology, and more. Congratulations to all involved.
➡️ Swiss medtech CeQur has raised $100m in a new series E funding round for what it called its “most ambitious phase of commercial growth.”
➡️ResMed has closed its $340m acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes the sleep tech giant beyond its core sleep apnea and respiratory care businesses.
➡️Prometheus, the physical AI startup co-founded by Jeff Bezos and Vik Bajaj, the former co-founder of Verily, Google’s life sciences unit, announced it raised $12bn
➡️Kardigan has sewn up its IPO plans, with the cardiovascular biotech expecting to bring in a cozy $320m from its planned Nasdaq listing.
➡️Thena Capital closes a £45m fund to back UK medtech, a first for an all-female GP team
➡️Swiss pharma giant Roche has signed a global licensing and collaboration agreement with US biotech Nurix Therapeutics to co-develop and co-commercialise bexobrutideg, an oral Bruton’s tyrosine kinase (BTK) degrader
➡️Predicta Biosciences, a precision oncology specialist, is teaming with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics clinic to offer an assay focused on blood cancers.
➡️Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125m series B with the backing of some of the biggest names in pharma.
➡️Ethyreal Bio has exited stealth with $101m in funding, joining the queue of companies preparing to challenge Amgen’s Tepezza.
➡️London-based Engitix Ltd has entered a strategic research collaboration and option agreement with GSK to discover and validate new therapeutic targets for liver fibrosis regression
➡️Oslo-based Circio has completed a NOK300m financing round, extending its runway to the end of 2030 and giving the company funds to advance its circVec circular RNA expression platform
➡️FesariusTherapeutics raises $20M to expand dermal repair technology
➡️GT Medical raises $100M for brain tumor tech after clinical trial success
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.